How big is the non-invasive cancer diagnostics market?

The global non-invasive cancer diagnostics market size was estimated at USD 80.87 billion in 2025 and is expected to reach USD 85.79 billion in 2026.

What is the non-invasive cancer diagnostics market growth?

The global non-invasive cancer diagnostics market is expected to grow at a compound annual growth rate of 7.1% from 2026 to 2033 to reach USD 139.09 billion by 2033.

Which segment accounted for the largest non-invasive cancer diagnostics market share?

North America dominated the non-invasive cancer diagnostics market with a share of 41.17% in 2025. This is attributable to increasing prevalence of cancer in the U.S. and Canada, development of advanced diagnostic technologies, and frequent product launches &ongoing clinical research initiatives.

Who are the key players in non-invasive cancer diagnostics market?

Some key players operating in the non-invasive cancer diagnostics market include Abbott Laboratories; GE HealthCare; Siemens Healthineers AG; Koninklijke Philips N.V.; Canon Medical Systems; F. Hoffmann-La Roche Ltd; Illumina, Inc; Guardant Health, Inc.; Thermo Fisher Scientific Inc.; FONAR Corporation.

What are the factors driving the non-invasive cancer diagnostics market?

Key factors that are driving the market growth include increasing prevalence of cancer, advancements in diagnostic technologies, and the growing initiatives undertaken by both public and private organizations to improve early detection and treatment.

Non-invasive Cancer Diagnostics Market Size, Share & Trends Report

Non-invasive Cancer Diagnostics Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Pathology-based Instruments, Imaging Instruments), By Technology (Imaging, Liquid Biopsy, Immunoassay), By Indication, By End Use, By Region, And Segment Forecasts

Market Segmentations

Non-Invasive Cancer Diagnostics Product Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
  - Pathology-based Instruments
    - Polymerase Chain Reaction (PCR) Instruments
    - Next-generation Sequencing (NGS) Instruments
    - Microarrays
  - Imaging Instruments
    - Magnetic Resonance Imaging (MRI)
    - Computed Tomography (CT)
    - Positron Emission Tomography (PET)
    - Mammography
    - Others (Ultrasound, etc.)
- Consumables
- Kits & Reagents
Non-Invasive Cancer Diagnostics Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Imaging
- Liquid Biopsy
- Immunoassay
Non-Invasive Cancer Diagnostics Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Cervical Cancer
- Skin Cancer
- Others (Thyroid Cancer, etc.)
Non-Invasive Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Others (Academic & Research Institutes, etc.)
Non-Invasive Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Non-Invasive Cancer Diagnostics Market, by Product
    - Instruments
      - Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
      - Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
    - Consumables
    - Kits & Reagents
  - North America Non-Invasive Cancer Diagnostics Market, by Technology
    - Imaging
    - Liquid Biopsy
    - Immunoassay
  - North America Non-Invasive Cancer Diagnostics Market, by Indication
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Blood Cancer
    - Liver Cancer
    - Cervical Cancer
    - Skin Cancer
    - Others (Thyroid Cancer, etc.)
  - North America Non-Invasive Cancer Diagnostics Market, by End Use
    - Hospitals
    - Diagnostic Laboratories
    - Others (Academic & Research Institutes, etc.)
  - U.S.
    - U.S. Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - U.S. Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - U.S. Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - U.S. Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Canada
    - Canada Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Canada Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Canada Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Canada Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Mexico
    - Mexico Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Mexico Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Mexico Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Mexico Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
- Europe
  - Europe Non-Invasive Cancer Diagnostics Market, by Product
    - Instruments
      - Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
      - Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
    - Consumables
    - Kits & Reagents
  - Europe Non-Invasive Cancer Diagnostics Market, by Technology
    - Imaging
    - Liquid Biopsy
    - Immunoassay
  - Europe Non-Invasive Cancer Diagnostics Market, by Indication
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Blood Cancer
    - Liver Cancer
    - Cervical Cancer
    - Skin Cancer
    - Others (Thyroid Cancer, etc.)
  - Europe Non-Invasive Cancer Diagnostics Market, by End Use
    - Hospitals
    - Diagnostic Laboratories
    - Others (Academic & Research Institutes, etc.)
  - UK
    - UK Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - UK Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - UK Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - UK Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Germany
    - Germany Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Germany Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Germany Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Germany Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - France
    - France Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - France Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - France Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - France Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Italy
    - Italy Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Italy Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Italy Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Italy Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Spain
    - Spain Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Spain Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Spain Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Spain Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
- Asia Pacific
  - Asia Pacific Non-Invasive Cancer Diagnostics Market, by Product
    - Instruments
      - Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
      - Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
    - Consumables
    - Kits & Reagents
  - Asia Pacific Non-Invasive Cancer Diagnostics Market, by Technology
    - Imaging
    - Liquid Biopsy
    - Immunoassay
  - Asia Pacific Non-Invasive Cancer Diagnostics Market, by Indication
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Blood Cancer
    - Liver Cancer
    - Cervical Cancer
    - Skin Cancer
    - Others (Thyroid Cancer, etc.)
  - Asia Pacific Non-Invasive Cancer Diagnostics Market, by End Use
    - Hospitals
    - Diagnostic Laboratories
    - Others (Academic & Research Institutes, etc.)
  - Japan
    - Japan Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Japan Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Japan Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Japan Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - China
    - China Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - China Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - China Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - China Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - India
    - India Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - India Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - India Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - India Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Australia & New Zealand
    - Australia & New Zealand Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Australia & New Zealand Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Australia & New Zealand Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Australia & New Zealand Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - South Korea
    - South Korea Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - South Korea Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - South Korea Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - South Korea Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
- Latin America
  - Latin America Non-Invasive Cancer Diagnostics Market, by Product
    - Instruments
      - Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
      - Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
    - Consumables
    - Kits & Reagents
  - Latin America Non-Invasive Cancer Diagnostics Market, by Technology
    - Imaging
    - Liquid Biopsy
    - Immunoassay
  - Latin America Non-Invasive Cancer Diagnostics Market, by Indication
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Blood Cancer
    - Liver Cancer
    - Cervical Cancer
    - Skin Cancer
    - Others (Thyroid Cancer, etc.)
  - Latin America Non-Invasive Cancer Diagnostics Market, by End Use
    - Hospitals
    - Diagnostic Laboratories
    - Others (Academic & Research Institutes, etc.)
  - Brazil
    - Brazil Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Brazil Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Brazil Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Brazil Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Argentina
    - Argentina Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Argentina Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Argentina Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Argentina Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
- Middle East & Africa
  - Middle East & Africa Non-Invasive Cancer Diagnostics Market, by Product
    - Instruments
      - Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
      - Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
    - Consumables
    - Kits & Reagents
  - Middle East & Africa Non-Invasive Cancer Diagnostics Market, by Technology
    - Imaging
    - Liquid Biopsy
    - Immunoassay
  - Middle East & Africa Non-Invasive Cancer Diagnostics Market, by Indication
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Blood Cancer
    - Liver Cancer
    - Cervical Cancer
    - Skin Cancer
    - Others (Thyroid Cancer, etc.)
  - Middle East & Africa Non-Invasive Cancer Diagnostics Market, by End Use
    - Hospitals
    - Diagnostic Laboratories
    - Others (Academic & Research Institutes, etc.)
  - South Africa
    - South Africa Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - South Africa Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - South Africa Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - South Africa Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - Saudi Arabia
    - Saudi Arabia Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - Saudi Arabia Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - Saudi Arabia Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - Saudi Arabia Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)
  - UAE
    - UAE Non-Invasive Cancer Diagnostics Market, by Product
      - Instruments
        
        Pathology-based Instruments
        
        Polymerase Chain Reaction (PCR) Instruments
        
        Next-generation Sequencing (NGS) Instruments
        
        Microarrays
        
        Imaging Instruments
        
        Magnetic Resonance Imaging (MRI)
        
        Computed Tomography (CT)
        
        Positron Emission Tomography (PET)
        
        Mammography
        
        Others (Ultrasound, etc.)
      - Consumables
      - Kits & Reagents
    - UAE Non-Invasive Cancer Diagnostics Market, by Technology
      - Imaging
      - Liquid Biopsy
      - Immunoassay
    - UAE Non-Invasive Cancer Diagnostics Market, by Indication
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Blood Cancer
      - Liver Cancer
      - Cervical Cancer
      - Skin Cancer
      - Others (Thyroid Cancer, etc.)
    - UAE Non-Invasive Cancer Diagnostics Market, by End Use
      - Hospitals
      - Diagnostic Laboratories
      - Others (Academic & Research Institutes, etc.)

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments